Evidence map›Paper›PMID 35922879›Full record

ArticleJournal of neuroimaging : official journal of the American Society of Neuroimaging2022

Skull metastases and osseous venous malformations: The role of diffusion-weighted and dynamic contrast-enhanced MRI.

Ryo Kurokawa, Mariko Kurokawa, Adam Holmes, Akira Baba, Jayapalli Bapuraj, Aristides Capizzano, John Kim, Ashok Srinivasan, Toshio Moritani

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Skull metastases and osseous venous malformations: The role of diffusion-weighted and dynamic contrast-enhanced MRI.Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ryo KurokawaDivision of Neuroradiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-1186-8900
Mariko KurokawaDivision of Neuroradiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-3907-9188
Adam HolmesDivision of Neuroradiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Akira BabaDivision of Neuroradiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0001-6913-5307
Jayapalli BapurajDivision of Neuroradiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Aristides CapizzanoDivision of Neuroradiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
John KimDivision of Neuroradiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Ashok SrinivasanDivision of Neuroradiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Toshio MoritaniDivision of Neuroradiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
University of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeSkull metastasis (SM) is a common secondary malignancy. We evaluated the diagnostic performance of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (MRI) in differentiating SM from osseous venous malformations and SM of various origins.

methodsThis study included 31 patients with SM (median age, 64 years; range, 41-87 years; 29 women; 24 and 7 patients with breast and non-small cell lung cancer, respectively) and 16 with osseous venous malformations (median age, 68 years; range, 20-81 years; 10 women) who underwent both DWI and dynamic contrast-enhanced MRI between January 2015 and October 2021. Normalized mean apparent diffusion coefficients (ADCs) and dynamic contrast-enhanced MRI parameters were compared between SM and osseous venous malformations, and between breast cancer and non-small cell lung cancer. Multivariate stepwise logistic regression analyses were performed to identify statistically significant parameters.

resultsPlasma volume and time-to-maximum enhancement were the most statistically significant parameters for differentiating SM from osseous venous malformations, with an area under the receiver operating characteristic curve of 0.962. The normalized mean ADC and peak enhancement values were the most statistically significant parameters for differentiating breast cancer from non-small cell lung cancer, with an area under the curve of 0.924.

conclusionsOur results highlight the efficacious diagnostic performance of DWI and dynamic contrast-enhanced MRI in distinguishing SM from osseous venous malformations and differentiating SM of various origins.

Indexed as

Breast NeoplasmsCarcinoma, Non-Small-Cell LungLung NeoplasmsAgedContrast MediaDiffusion Magnetic Resonance ImagingFemaleHumansMagnetic Resonance ImagingMiddle AgedRetrospective StudiesSkullSpineVascular MalformationsContrast Mediadiffusion-weighted imagingdynamic contrast-enhancedosseous venous malformationskull metastasis

Identifiers

PMID35922879
OpenAlexW4289711135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.